Euronext Paris · Basic Materials
Invest in Amoéba stock from India
Indian and foreign residents can buy Amoéba (ALMIB) shares directly through Paasa.
By Paasa · Updated
Amoéba at a glance
- Price
- €0.32-€0.01 (3.61%)
- Market cap
- €24.89M
- Day range
- €0.30 – €0.33
- P/E
- -2.29
- Dividend yield
- None
- Volume
- 1.12M
- 1 month
- -53.89%
- 6 months
- -60.25%
- YTD
- -69.81%
- 1 year
- -67.68%
- 5 years
- -80.77%
Amoéba statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €0.0 | €601.6K | €664.3K | €0.0 | €0.0 |
| Gross profit | −€973.0K | −€805.6K | −€1.7M | −€1.0M | −€858.9K |
| Operating income | −€8.2M | −€6.9M | −€14.0M | −€6.3M | −€6.2M |
| Net income | −€8.3M | −€6.6M | −€14.3M | −€8.0M | −€7.8M |
| Earnings per share | −€0.12 | −€0.13 | −€0.29 | −€0.24 | −€0.44 |
| EBITDA | −€7.2M | −€5.4M | −€13.7M | −€5.3M | −€5.0M |
| Total assets | €10.1M | €5.7M | €6.3M | €12.4M | €14.5M |
| Total debt | €12.2M | €12.1M | €4.9M | €2.4M | €12.5M |
| Cash and short-term investments | €4.7M | €458.9K | €519.3K | €5.5M | €7.3M |
| Shareholders' equity | −€5.4M | −€10.4M | −€3.9M | €8.2M | €213.7K |
| Operating cash flow | −€6.1M | −€4.2M | −€6.5M | −€5.4M | −€5.9M |
| Free cash flow | −€7.4M | −€4.8M | −€12.6M | −€5.7M | −€6.0M |
| Capital expenditure | −€1.3M | −€564.7K | −€6.1M | −€305.7K | −€144.6K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Installux | ALLUX.PA | €490.00 | €136.91M |
| Afyren | ALAFY.PA | €2.63 | €101.55M |
| Carbios | ALCRB.PA | €5.91 | €99.71M |
| Baikowski | ALBKK.PA | €20.10 | €73.75M |
| Moulinvest | ALMOU.PA | €22.70 | €68.69M |
| Hoffmann Green Cement Technologies | ALHGR.PA | €3.95 | €64.62M |
| ZCCM Investments | MLZAM.PA | €4.20 | €62.81M |
| Herige | ALHRG.PA | €17.90 | €51.28M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Amoéba from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search ALMIB and buy
Find Amoéba by name or by its ticker, ALMIB, and place your order.
Why invest in Amoéba from India
What Amoéba does
Amoéba S.A. focuses on the development and commercialization of anti-microbial and anti-fungal products. The company's primary innovation centers on harnessing the unique properties of the Willaertia magna C2c Maky amoeba, which it is applying across various fields. Amoéba operates in the Agricultural Inputs industry within the Basic Materials sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Amoéba stock from India?
Yes. Indian residents and NRIs can buy Amoéba (ALMIB) shares directly through Paasa. Amoéba is listed on Euronext Paris, in the Agricultural Inputs industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Amoéba shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.